LBO — ATRIUM HEALTH STANLY
IRR: 16.2% | MOIC: 2.11x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.2%
IRR
2.11x
MOIC
$150.6M
Entry EV
$222.8M
Exit EV
$77.5M
Equity Invested
Sources & Uses
S&UTotal · $150.6M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $58.5M | 38.8% | |
| Sub Debt | $14.6M | 9.7% | |
| Equity | $77.5M | 51.5% | |
| Enterprise Value | $146.2M | 97.1% | |
| Transaction Fees | $4.4M | 2.9% | |
| Total Uses | $150.6M | 100.0% |
Interpretation
INTAt 2.11x MOIC and 16.2% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $21.2M |
| Exit Ev | $222.8M |
| Net Debt At Exit | $59.1M |
| Equity At Exit | $163.8M |
| Equity Invested | $77.5M |
| Total Value Created | $86.3M |
| Value From Growth | $69.3M |
| Value From Multiple | $7.3M |
| Value From Deleveraging | $14.0M |